A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2

Abstract The SARS-CoV-2 mRNA vaccine provides effective protection against viral infection and severe disease by inducing efficient adaptive immunity. However, vaccine efficacy is decreased against emerging variants, and immune memory is relatively short-lived. Here, we added new T cell epitopes to...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Jing Wen, Jaesu Moon, Luca Tucciarone, Te-Hsuan Bu, Amanda Y. Sun, Robyn Miller, Julia Timis, Lujing Wu, Davey M. Smith, Sujan Shresta, Kyle J. Gaulton, Tariq M. Rana
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2026-03-01
Reeks:	npj Vaccines
Online toegang:	https://doi.org/10.1038/s41541-026-01421-z
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!